Clinical Trial Update: Local, Targeted Therapy With Alpha Emitter [225Ac]Ac-DOTA-SP (TAT) in Glioma (WHO G3-G4) Progression [NA]

View source ↗

Summary

This entry notes that recruitment is ongoing for a local alpha-emitter therapy, [225Ac]Ac-DOTA-SP (TAT), being studied for glioblastoma and other high-grade gli…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anaplastic Astrocytoma
• Glioblastoma
• High-grade Glioma

Drugs mentioned

• [225Ac]Ac-DOTA-SP (TAT)

Snippet

Sponsor: Medical University of Warsaw | Conditions: Glioblastoma, High-Grade Gliomas | NA | Status: RECRUITING